Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioPhausia (OTC products)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of OTC products comprising of novalucol, novalucid, c-vimin and resulax brands.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Products
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Blasieholmsgatan 2
  • 111 48 Stockholm
  • Sweden

BioPhausia (OTC products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioPhausia (OTC products)‘s full profile, request access.

Request full access to PitchBook

BioPhausia (OTC products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore BioPhausia (OTC products)‘s full profile, request access.

Request full access to PitchBook